Position

Clarius Group, LLC in Neumora Therapeutics, Inc.

Back to the book · All holders of NMRA

Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.